<DOC>
	<DOCNO>NCT00012558</DOCNO>
	<brief_summary>A long-term study current treatment bipolar disorder , include medication psychosocial therapy .</brief_summary>
	<brief_title>Systematic Treatment Enhancement Program Bipolar Disorder ( STEP-BD )</brief_title>
	<detailed_description>STEP-BD evaluate best-practice treatment option use bipolar disorder : mood-stabilizing medication , antidepressant , atypical antipsychotic , psychosocial intervention - `` talk '' therapy - include Cognitive Behavioral Therapy , Family-focused Therapy , Interpersonal Social Rhythm Therapy , Collaborative Care ( psychoeducation ) . There two kind treatment `` pathway '' STEP-BD , participant may opportunity take part . The medication psychosocial intervention provide pathway consider among best choice treatment bipolar disorder everyday clinical practice . In `` Best Practice Pathway , '' participant follow STEP-BD certify doctor treatment choice individualize . Everyone enrol STEP-BD may participate pathway . Participants doctor work together decide best treatment plan change plan need . Also , anyone wish stay current treatment upon enter STEP-BD may pathway . Adolescents adults age 15 year old may participate Best Practice Pathway . For adults age 18 old , another way participate STEP-BD `` Randomized Care Pathways . '' Depending symptom , participant may offer treatment one pathways course study . The participant remain mood-stabilizing medication . However , doctor uncertain several treatment strategy work best bipolar disorder , another medication and/or talk therapy may add . Each Randomized Care Pathway involve different set additional treatment . Unlike Best Practice Pathway , participant Randomized Care Pathways randomly assign treatment . Also , case , neither participant doctor tell different medication add . This call `` double-blind '' study do medication effect evaluate objectively , without unintended bias may come knowing assign . Participants assign medication bad reaction past , strongly oppose , doctor feel unsuitable . The medication ( ) participant may randomly assign Randomized Care Pathways free charge . There treatment option participant respond well treatment assign . Also , participant may return Best Practice Pathway time . About 1,500 individual enrol least one Randomized Care Pathway period participation STEP-BD . It important note STEP-BD provide continuity care . For example , participant start Best Practice Pathway later choose enter one Randomized Care Pathways , continue STEP-BD doctor treatment team . Then , complete Randomized Care Pathway , participant may return Best Practice Pathway ongoing , individually-tailored treatment .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Lamotrigine</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Inositol</mesh_term>
	<mesh_term>Tranylcypromine</mesh_term>
	<criteria>General current age 15 older ( Best Practice Pathway ) 18 year old ( Randomized Care Pathways ) ; able give inform consent data harvest ; meet DSMIV criterion Bipolar I Disorder , Bipolar II Disorder , Bipolar Disorder NOS , Cyclothymic Disorder ; undergo complete standard evaluation include clinical interview , self rating , laboratory study ; meet Clinical Specialist schedule ; able complete Study Registry Forms within 3 month registration . General unwilling unable adhere basic study requirement ( i.e. , complete rating form , attend schedule evaluation ) ; competent give inform consent opinion investigator ( e.g. , psychotic ) . Participants ask remain study five year investigator document evaluate longterm treatment outcome . Participants meet STEPBD psychiatrist periodic evaluation and/or treatment adjustment course study , fill various selfrating form , applicable , participate psychotherapy . One psychotherapy option , FamilyFocused Therapy , require participant family attend counsel session together . Overall , estimate amount time require participant study 2 4 hour per month .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>Psychotic Disorders</keyword>
	<keyword>Mood Disorders</keyword>
	<keyword>Manic-Depressive Illness</keyword>
	<keyword>Hypomania</keyword>
	<keyword>Mania</keyword>
	<keyword>Mood Stabilizer</keyword>
</DOC>